Oct 25, 2023Anavex Life Sciences Reports New Publication in Scientific Journal Demonstrating the Potential of
Sep 14, 2023Anavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in Patients with Alzheimer’s Disease
Sep 12, 2023Anavex Announces Appointment of Dr Marwan N Sabbagh, MD as Chairman of the Scientific Advisory Board
Jun 28, 2023Long-term Clinical Study Demonstrates Disease-Modifying Effects of ANAVEX®2-73 for Rett Syndrome